1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Marie Wislez, Julien Mazières, A. Lavolé, Gérard Zalcman, O. Carré, Thomas Egenod, R. Caliandro, R. Gervais, G. Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin, Françoise Le Pimpec‐Barthes, L. Brouchet, Jalal Assouad, B. Milleron, Diane Damotte, Martine Antoine, Virginie Westeel
Topics & Concepts
MedicineDurvalumabClinical endpointSurgeryPneumonectomyInternal medicineLung cancerCancerRandomized controlled trialNivolumabImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging